• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Profound Medical Corp. - common stock (NQ:PROF)

8.220 -0.120 (-1.44%)
Streaming Delayed Price Updated: 4:00 PM EST, Jan 16, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Profound Medical Corp. - common stock

< Previous 1 2 3 4 5 Next >
News headline image
Profound Medical and Siemens Healthineers to Offer a Complete Solution for MRI-guided Prostate Therapy
December 02, 2024
From Profound Medical Corp.
Via GlobeNewswire
News headline image
Profound Medical to Unveil Next TULSA-AI® Module, ‘UA Alignment Assistant’
November 26, 2024
TULSA procedure’s unrivaled flexibility, real-world efficacy and ongoing CAPTAIN post-market study to be featured in the scientific programs at the upcoming RSNA and SUO meetings 
From Profound Medical Corp.
Via GlobeNewswire
News headline image
Profound Medical to Participate in the Stifel 2024 Healthcare Conference
November 12, 2024
From Profound Medical Corp.
Via GlobeNewswire
News headline image
Profound Medical: Q4 Earnings Insights ↗
March 07, 2024
 
Via Benzinga
News headline image
Profound Medical Announces Third Quarter 2024 Financial Results
November 07, 2024
From Profound Medical Corp.
Via GlobeNewswire
News headline image
Profound Medical Announces TULSA Reimbursement Raised to Urology APC Level 7 Under CMS Outpatient Prospective Payment System (OPPS) Final Rule for CY2025
November 04, 2024
From Profound Medical Corp.
Via GlobeNewswire
News headline image
Profound Medical to Release Third Quarter 2024 Financial Results on November 7 – Conference Call to Follow
October 17, 2024
From Profound Medical Corp.
Via GlobeNewswire
News headline image
Profound Medical Appoints Tom Tamberrino as Chief Commercial Officer
October 16, 2024
From Profound Medical Corp.
Via GlobeNewswire
News headline image
iAccess Alpha's Buyside Best Ideas Virtual Fall Conference September 24-25, 2024
September 20, 2024
Via ACCESSWIRE
News headline image
Profound Medical’s PRO-Talk Live! Event Features the Present and Future of TULSA
September 16, 2024
From Profound Medical Corp.
Via GlobeNewswire
News headline image
Profound Medical to Participate in Lake Street’s Best Ideas Growth Conference
September 04, 2024
From Profound Medical Corp.
Via GlobeNewswire
News headline image
PROF Stock Earnings: Profound Medical Beats EPS, Misses Revenue for Q2 2024 ↗
August 08, 2024
PROF stock results show that Profound Medical beat analyst estimates for earnings per share but missed on revenue for the second quarter of 2024. 
Via InvestorPlace
News headline image
Profound Medical Announces Second Quarter 2024 Financial Results
August 08, 2024
From Profound Medical Corp.
Via GlobeNewswire
News headline image
Profound Medical to Release Second Quarter 2024 Financial Results on August 8 – Conference Call to Follow
July 18, 2024
From Profound Medical Corp.
Via GlobeNewswire
News headline image
Microsoft To Rally Around 6%? Here Are 10 Top Analyst Forecasts For Tuesday ↗
July 16, 2024
 
Via Benzinga
News headline image
Profound Medical Announces Category 1 CPT Codes Proposed CY2025 Rule for TULSA to Treat Prostate Diseases
July 11, 2024
From Profound Medical Corp.
Via GlobeNewswire
News headline image
Profound Medical Annual General Meeting of Shareholders Voting Results
May 15, 2024
From Profound Medical Corp.
Via GlobeNewswire
News headline image
Profound Medical Receives U.S. FDA 510(k) Clearance for ‘Contouring Assistant’ AI Module that Enables Creation of an Automated TULSA Treatment Plan
May 14, 2024
From Profound Medical Corp.
Via GlobeNewswire
News headline image
PROF Stock Earnings: Profound Medical Beats EPS, Misses Revenue for Q1 2024 ↗
May 09, 2024
PROF stock results show that Profound Medical beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2024. 
Via InvestorPlace
News headline image
Profound Medical Announces First Quarter 2024 Financial Results and Issues Full-Year 2024 Revenue Guidance
May 09, 2024
From Profound Medical Corp.
Via GlobeNewswire
News headline image
Growing Body of Clinical Evidence Points to the Potential of Profound Medical’s TULSA Procedure Becoming a Mainstream Treatment Modality Across the Entire Prostate Disease Spectrum
May 06, 2024
From Profound Medical Corp.
Via GlobeNewswire
News headline image
Profound Medical to Release First Quarter 2024 Financial Results on May 9 – Conference Call to Follow
April 22, 2024
From Profound Medical Corp.
Via GlobeNewswire
News headline image
Profound Medical to Participate in the 2024 Bloom Burton & Co. Healthcare Investor Conference
April 09, 2024
From Profound Medical Corp.
Via GlobeNewswire
News headline image
PROF Stock Earnings: Profound Medical Misses EPS, Beats Revenue for Q4 2023 ↗
March 07, 2024
PROF stock results show that Profound Medical missed analyst estimates for earnings per share but beat on revenue for the fourth quarter of 2023. 
Via InvestorPlace
News headline image
Profound Medical Announces Fourth Quarter and Full Year 2023 Financial Results
March 07, 2024
From Profound Medical Corp.
Via GlobeNewswire
News headline image
Earnings Scheduled For March 7, 2024 ↗
March 07, 2024
Companies Reporting Before The Bell • CI&T (NYSE:CINT) is estimated to report quarterly earnings at $0.06 per share on revenue of $106.08 million. 
Via Benzinga
News headline image
Profound Medical to Participate in Barclays 26th Annual Global Healthcare Conference
March 04, 2024
From Profound Medical Corp.
Via GlobeNewswire
News headline image
Profound Medical in Collaboration with Siemens Healthineers to Further Expand Physician and Patient Access to the TULSA Procedure
February 27, 2024
From Profound Medical Corp.
Via GlobeNewswire
News headline image
Profound Medical to Release Fourth Quarter and Full Year 2023 Financial Results on March 7 – Conference Call to Follow
February 15, 2024
From Profound Medical Corp.
Via GlobeNewswire
News headline image
Profound Medical Announces Non-Brokered Private Placement
January 16, 2024
From Profound Medical Corp.
Via GlobeNewswire
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap